Astrana Health (NASDAQ:ASTH) Lowered to "Strong Sell" Rating by Zacks Research

Key Points

• Astrana Health (NASDAQ:ASTH) has been downgraded by Zacks Research from a "strong-buy" rating to a "strong sell" rating.
• The company's recent earnings report showed a missed EPS estimate of $0.19, compared to a consensus estimate of $0.36, although it achieved revenue of $654.81 million.
• Institutional investors hold 52.77% of Astrana Health's shares, with significant positions recently acquired by firms like Vanguard Group Inc. and Jacobs Levy Equity Management Inc.

Zacks Research downgraded shares of Astrana Health (NASDAQ:ASTH - Free Report) from a strong-buy rating to a strong sell rating in a report released on Monday,Zacks.com reports.

Astrana Health Trading Down 3.6%

Shares of ASTH traded down $1.12 during mid-day trading on Monday, reaching $29.70. 359,392 shares of the company were exchanged, compared to its average volume of 452,868. The business has a 50 day simple moving average of $26.48 and a two-hundred day simple moving average of $28.13. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. The stock has a market capitalization of $1.66 billion, a PE ratio of 58.24, a PEG ratio of 0.74 and a beta of 0.85. Astrana Health has a 52 week low of $21.20 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business had revenue of $654.81 million during the quarter, compared to analyst estimates of $639.13 million. During the same period last year, the firm posted $0.40 earnings per share. Astrana Health's quarterly revenue was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. On average, analysts predict that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Astrana Health by 7.1% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,657 shares of the company's stock valued at $265,000 after purchasing an additional 710 shares during the last quarter. Police & Firemen s Retirement System of New Jersey increased its position in shares of Astrana Health by 8.0% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 9,930 shares of the company's stock valued at $247,000 after purchasing an additional 734 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Astrana Health by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after purchasing an additional 915 shares during the last quarter. US Bancorp DE grew its position in Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after acquiring an additional 1,015 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in Astrana Health by 19.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock worth $225,000 after acquiring an additional 1,184 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.